Skip to content
AlternativeMed

THCP (Tetrahydrocannabiphorol): Identity, Occurrence and Evidence

What THCP is, how it was found in the plant, what laboratory and animal work suggests about its strength, and why human safety data are missing.

Content last updated . This page has not been medically reviewed.

Short answer

THCP (tetrahydrocannabiphorol) is a THC-like compound. It was reported in 2019 as a newly identified natural cannabinoid with the same structure as delta-9 THC except for a longer, seven-unit side chain. [1] It is now also sold in consumer products. Human research is almost absent. NIDA lists THCP among compounds with limited research on health effects. [2] This guide uses plain evidence labels: preclinical (cells/animals only), insufficient evidence, evidence of harm and marketing claim. "Proper evidence not found" means we looked and found nothing usable. See also THC.

What it is and how it was found

Researchers reported delta-9-THCP when trying to define the cannabinoid profile of a medicinal cannabis variety. They isolated it, confirmed its structure by matching it to a lab-made copy, and also found a CBD-type partner with the same long chain. [1] A later study measured these long-chain compounds in 49 cannabis samples of four chemotypes, after noting open questions about how present and abundant they are. [3] A 2025 case report says delta-9-THCP is found naturally in the plant in small quantities. [4]

Occurrence, in plain terms: it is real, but a trace compound. We did not find a sourced figure for typical amounts in plant material, so we give none. Composition varies, and an isolate sold in a product is not the same thing as the tiny natural amount. See cannabis chemistry.

What laboratory work shows

  • Receptor binding. In the original study, delta-9-THCP bound the human CB1 receptor in vitro about as strongly as a potent reference agonist called CP55940. [1]
  • Animal test. In the classic cannabinoid "tetrad" test, it produced reduced movement, pain relief, catalepsy and lower body temperature, which the authors read as THC-like activity. [1]
  • Cell comparison. A 2024 assay of 30 THC-related compounds found that THCP and several other analogs showed higher potential for CB1 activation than delta-9 THC, by either efficacy or potency. [5]

Label: preclinical (cells/animals only). Strong binding in a dish does not give a reliable measure of strength in people, and it does not tell us how long effects last or how risky a given amount is.

What research shows in people

Controlled human studies: Proper evidence not found. We searched PubMed for tetrahydrocannabiphorol and found chemistry, forensic and case-report papers, but no human trial of effects, benefit or safety.

A 2025 case report described a regular THC user brought to an emergency department with psychotic symptoms that lasted about 48 hours and a self-inflicted injury after a single use of delta-9-THCP. [4] The authors say information on delta-9-THCP is sparse and that even experienced THC users might react differently. [4] Label: evidence of harm signal from a single case, not a risk rate.

In the marketplace

  • Product contents. An Italian study of 26 online low-THC products found delta-9-THCP in 19.2% of them and delta-8-THCP in 15.4%; 92.3% of the products were mislabeled overall. [6] A German analysis of 80 seized products also looked for THCP among other semisynthetic cannabinoids. [7]
  • Natural versus made-in-lab. Product labels rarely show whether THCP came from the plant or was made from another compound. We did not find a source that settles this for consumer products, so Proper evidence not found.

Special groups

Children, people who are pregnant or breastfeeding, and people with psychosis, mania or heart conditions should not treat a high-strength THC-type product as safe by default. Proper evidence not found on THCP-specific safety in any of these groups. See psychosis and mania vulnerability and pregnancy and breastfeeding.

Legal status (read 2026-10-22; not legal advice)

  • United States, federal. The DEA's 2020 interim final rule says synthetically derived tetrahydrocannabinols remain Schedule I. [8] A November 2025 law that takes effect on November 12, 2026 excludes hemp products with cannabinoids not naturally made by the plant, or made naturally but synthesized or manufactured outside it. [9] We did not read a regulator page that names THCP, so we do not state its category.
  • Elsewhere. Not verified. See cannabis laws by country.

How to evaluate a THCP claim

"More potent", "natural" and "legal" are marketing claims unless backed by a source. Ask for a batch lab report that names THCP and lists its date and method, and remember a lab report shows content only. See how to read a cannabis COA.

Frequently asked questions

What does THCP stand for?

Tetrahydrocannabiphorol, a compound with the THC structure but a seven-unit side chain. [1]

Is THCP stronger than THC?

In laboratory work it bound CB1 strongly and, in one cell assay, showed higher CB1 activation potential than delta-9 THC. [1][5] No human comparison has been done in the sources we read.

Is THCP natural?

It was isolated from the plant, but only small amounts are found naturally. [4]

Is THCP safe?

Safety has not been established. One case report describes psychosis after a single use. [4]

References

  1. Citti et al. A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than delta9-tetrahydrocannabinol: delta9-Tetrahydrocannabiphorol. Scientific reports. 2019. PubMed abstract read 2026-10-22.
  2. National Institute on Drug Abuse (NIDA). Cannabis (Marijuana) DrugFacts. Read 2026-10-22.
  3. Linciano et al. The novel heptyl phorolic acid cannabinoids content in different Cannabis sativa L. accessions. Talanta. 2021. PubMed abstract read 2026-10-22.
  4. Greer et al. Psychosis and suicide attempt following a single use of delta-9-tetrahydrocannabiphorol: A case report. PCN reports. 2025. PubMed abstract read 2026-10-22.
  5. Janssens et al. Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with beta-arrestin2 recruitment assays. Archives of toxicology. 2024. PubMed abstract read 2026-10-22.
  6. Giorgetti et al. Forensic profiling of synthetic and semi-synthetic cannabinoids in legal cannabis products in Italy. Forensic science international. 2026. PubMed abstract read 2026-10-22.
  7. Hundertmark et al. Characterising a New Cannabis Trend: Extensive Analysis of Semi-Synthetic Cannabinoid-Containing Seizures From Germany. Drug testing and analysis. 2025. PubMed abstract read 2026-10-22.
  8. Drug Enforcement Administration, US Department of Justice. Implementation of the Agriculture Improvement Act of 2018 (interim final rule). Federal Register, 21 August 2020. Read 2026-10-22.
  9. Congressional Research Service. Change to Federal Definition of Hemp and Implications for Federal Enforcement. CRS Insight IN12620, 3 December 2025. Read 2026-10-22.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.